StockDriftsStockDriftsTop 2 Wuxi Apptec Co., Ltd. Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| LYEL | LYELL IMMUNOPHARMA INC | 53.56% | 7.39M | $10.2M | -3.79%(-291.45K) | — | 2024-09-30 | |
| ADAG | ADAGENE INC | 46.44% | 3.98M | $8.8M | +0.00%(+0) | — | 2024-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Wuxi Apptec Co., Ltd. reports $19.04M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are LYEL (53.6%) and ADAG (46.4%). Figures reflect the Q3 2024 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Wuxi Apptec Co., Ltd., compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Wuxi Apptec Co., Ltd.’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1832424). View Wuxi Apptec Co., Ltd.’s 13F filings on SEC